Home›Companies›Diligent Pharma

Diligent Pharma, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 16, 2023·Suggest an edit

About Diligent Pharma

Diligent Pharma is a private company based in Princeton, New Jersey, incorporated in 2018 in Delaware. It has reported $3,500,000 raised in one offering on Form D since February 2023. Its chief executive is Patricia Leuchten.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 2, 2023Feb 16, 2023$3,500,000of $9.2M target2$1.7MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Diligent Pharma's Form D filed Feb 16, 2023.

PL
Patricia Leuchten
Chief Executive Officer

Sources

  1. SECDiligent Pharma, Inc. filing history